- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
MCM3/Cell Cycle Marker Antibody (clone MCM3/3221) recognizes Minichromosome maintenance complex component 3, a core subunit of the MCM2-7 helicase complex that functions as a DNA replication licensing factor. MCM3 antibody is widely used as a cell cycle marker antibody because MCM3 protein expression is tightly linked to cell proliferation and S phase entry. The MCM3 gene encodes a nuclear protein that participates in formation of the pre-replication complex during G1 phase, ensuring that DNA replication occurs once per cell cycle.
MCM3 protein forms a heterohexameric complex with MCM2, MCM4, MCM5, MCM6, and MCM7. This complex acts as a replicative helicase that unwinds DNA at replication origins, allowing DNA polymerases to initiate synthesis. As a cell cycle marker antibody, MCM3 Antibody detects nuclei of cells that are licensed for replication, including cells in late G1, S, G2, and early mitosis. In contrast to markers restricted to active DNA synthesis, MCM3 highlights a broader proliferative compartment, making it useful for assessing growth fraction in tissues.
In normal tissues, MCM3 expression is observed in proliferative zones such as basal epithelial layers, germinal centers of lymphoid tissue, and stem or progenitor cell populations. Differentiated, quiescent, or terminally specialized cells typically show little to no MCM3 staining. In tumor pathology, MCM3 Antibody is frequently applied as a cell cycle marker antibody to evaluate proliferative activity in carcinomas, lymphomas, and other neoplasms. Elevated nuclear MCM3 staining correlates with increased tumor grade, aggressive behavior, and poor clinical outcome in several cancer types.
MCM3 protein is localized predominantly in the nucleus, where it associates with chromatin during replication licensing. Its expression is regulated by cell cycle dependent kinases and E2F transcription factors, linking MCM3 levels to key oncogenic pathways. Because deregulated replication licensing contributes to genomic instability, detection of MCM3 provides insight into aberrant cell cycle control in cancer. Clone MCM3/3221 is designed to detect endogenous MCM3 protein in research applications, supporting studies of DNA replication, tumor proliferation, and cell cycle regulation in both normal and malignant tissues.
Overall, MCM3/Cell Cycle Marker (clone MCM3/3221) serves as a robust tool for identifying proliferating cells and characterizing replication licensing activity across a wide range of experimental and pathological contexts.
Optimal dilution of the recombinant MCM3/Cell Cycle Marker antibody should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 650-750) from the human protein was used as the immunogen for the recombinant MCM3/Cell Cycle Marker antibody.
Aliquot the recombinant MCM3/Cell Cycle Marker antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.